Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Serum ferritin below 50 ng/mL is a red flag in restless legs syndrome because brain iron sits downstream of blood iron, and low stores impair dopamine signaling in the substantia nigra, intensifying the nightly urge to move, crawling sensations, and sleep disruption. Standard lab guidance includes fasting morning ferritin, transferrin saturation (TSAT), serum iron, and CRP, since inflammation can falsely elevate ferritin and mask true depletion, and many clinicians target ferritin above 75 to 100 ng/mL with TSAT above 20% before symptoms reliably improve. There are several important factors to consider, including test timing, oral versus IV iron thresholds, and other conditions that mimic RLS, so see below to understand the full picture before acting on a single number.
Because iron results are only one piece of the puzzle and severe leg symptoms can also stem from neuropathy, medication side effects, kidney issues, or pregnancy-related changes, it helps to map your specific pattern before your next appointment. Take a free, instant, online symptom check to better understand what may be driving your symptoms, which labs to request, and the smartest next steps.
Last reviewed for medical accuracy: 08/18/2026
Restless legs syndrome (RLS) is a common neurological disorder characterized by an irresistible urge to move the legs, often accompanied by uncomfortable tingling or crawling sensations. Symptoms typically worsen at night or during periods of rest, disrupting sleep and daily life. One of the most important—and modifiable—risk factors for RLS is low iron stores in the brain, which often correlates with low blood ferritin levels.
When ferritin in the blood drops, the brain’s iron supply can fall below the level needed for normal neurotransmitter activity. Studies show that brain regions involved in movement (especially the basal ganglia) suffer when iron levels are insufficient, directly linking low ferritin to RLS severity.
Clinical research and expert consensus point to a critical threshold around 50 ng/mL of serum ferritin. Here’s why values under this level often correspond to severe RLS symptoms:
Dopamine Dysfunction
Iron is a co-factor for tyrosine hydroxylase, the enzyme that produces dopamine. When iron is low:
Myelin and Nerve Health
Iron supports myelin formation, the protective sheath around nerves. Deficient myelin:
Neuroimaging Evidence
MRI studies demonstrate reduced iron content in the substantia nigra and thalamus of RLS patients with low ferritin, directly correlating with symptom severity.
Clinical Trials
Trials of iron supplementation show significant symptom improvement when ferritin rises above 50 ng/mL—and even more so when it approaches 75 ng/mL.
Taken together, these factors explain why falling below the 50 ng/mL mark often heralds a marked increase in restless legs discomfort.
When managing RLS, clear guidelines help both patients and doctors decide when to test, how to interpret results, and when to treat. Here are the core “ferritin blood test rules” for RLS:
75 ng/mL: Generally sufficient, but monitor if symptoms persist (other causes may apply).
Following these rules helps ensure both safety and efficacy in addressing restless legs through iron repletion.
Preparation
Key Lab Values to Check
Interpreting Results
When to Retest
Addressing low ferritin can dramatically improve RLS. Work with your healthcare provider to choose the best approach:
Regular follow-up blood tests can confirm that your ferritin is rising above the 50 ng/mL threshold, effectively reducing RLS severity. In many cases, pushing toward 75 ng/mL offers even better symptom control.
If you’re experiencing new or worsening symptoms, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Always remember: although low ferritin is a key factor in RLS, other serious causes (such as neuropathy, kidney disease, or medication side effects) may mimic or worsen restless legs. Speak to a doctor about anything that could be life threatening or seriously affecting your health. Regular monitoring and a personalized treatment plan are the safest ways to manage RLS and reclaim restful nights.
(References)
* Allen RP, Picchietti DL, Auerbach M, Cho YW, Connor JR, Earley CJ, Garcia-Borreguero D, Kotagal S, Manconi M, Ondo W, Ulfberg J, Winkelman JW, International Restless Legs Syndrome Study Group (IRLSSG). Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report. Sleep Med. 2018 Jan;41:27-44. doi: 10.1016/j.sleep.2017.11.1126. Epub 2017 Nov 24. PMID: 29425576.
* Trenkwalder C, Allen R, Högl B, Clemens S, Patton S, Schormair B, Winkelmann J. Comorbidities, treatment, and pathophysiology in restless legs syndrome. Lancet Neurol. 2018 Nov;17(11):994-1005. doi: 10.1016/S1474-4422(18)30311-9. Epub 2018 Sep 21. PMID: 30244828.
* Gossard TR, Trotti LM, Videnovic A, St Louis EK. Restless Legs Syndrome: Contemporary Diagnosis and Treatment. Neurotherapeutics. 2021 Jan;18(1):140-155. doi: 10.1007/s13311-021-01019-4. Epub 2021 Apr 20. PMID: 33880737; PMCID: PMC8116476.
* Manconi M, Garcia-Borreguero D, Schormair B, Videnovic A, Berger K, Ferri R, Dauvilliers Y. Restless legs syndrome. Nat Rev Dis Primers. 2021 Nov 3;7(1):80. doi: 10.1038/s41572-021-00311-z. Epub 2021 Nov 3. PMID: 34732752.
* Zink N. Restless-Legs-Syndrom: Eisenstoffwechsel optimieren! MMW Fortschr Med. 2023 Feb;165(3):12-14. doi: 10.1007/s15006-023-2296-2. PMID: 36759450.
* Safarpour Y, Vaziri ND, Jabbari B. Restless Legs Syndrome in Chronic Kidney Disease- a Systematic Review. Tremor Other Hyperkinet Mov (N Y). 2023;13:10. doi: 10.5334/tohm.752. Epub 2023 Mar 29. PMID: 37008995; PMCID: PMC10064886.
* Nanayakkara B, Di Michiel J, Yee BJ. Restless legs syndrome. Aust J Gen Pract. 2023 Sep;52(9):615-621. doi: 10.31128/AJGP-02-23-6722. PMID: 37666782.
* Castillo-Álvarez F, Marzo-Sola ME. Restless legs syndrome. Pathophysiology, diagnosis and treatment. Med Clin (Barc). 2025 Jan 24;164(2):84-90. doi: 10.1016/j.medcli.2024.05.026. Epub 2024 Aug 28. PMID: 39209614.
* Winkelman JW, Berkowski JA, DelRosso LM, Koo BB, Scharf MT, Sharon D, Zak RS, Kazmi U, Falck-Ytter Y, Shelgikar AV, Trotti LM, Walters AS. Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2025 Jan 1;21(1):137-152. doi: 10.5664/jcsm.11390. PMID: 39324694; PMCID: PMC11701286.
* Auerbach M, DeLoughery TG, Tirnauer JS. Iron Deficiency in Adults: A Review. JAMA. 2025 May 27;333(20):1813-1823. doi: 10.1001/jama.2025.0452. PMID: 40159291.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.